arrow
S

Sara M. Mangsbo

Uppsala University
H指数:34
被引数:3,262

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange

通过氨基酸交换调节抗原处理以优化靶向肽抗原递送中的T细胞反应

2026-02-280
OAAI
A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice

一种双特异性CD40激动性抗体,允许抗体-肽缀合物形成,以实现癌症特异性肽递送,从而改善小鼠的T增殖和抗肿瘤免疫力

2024-11-050
OAAI
Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination

ipilimumab和hTERT疫苗联合治疗后T细胞受体库和黑色素瘤肿瘤微环境的表征

2022-09-1115
OAAI
Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology
2022-03-146
OAAI
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines

用ChAdOx1 nCoV-19和BNT162b2 mRNA疫苗进行同源或异源初次预防接种后,SARS-CoV-2免疫反应的持续时间长达六个月

2022-02-2412
OAAI
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19
2021-09-2745
OAAI